Jabbari Neurology Ltd 16654312 false 2025-08-15 2026-08-31 2026-08-31 The principal activity of the company is healthcare. Digita Accounts Production Advanced 6.30.9574.0 true 16654312 2025-08-15 2026-08-31 16654312 2026-08-31 16654312 core:CurrentFinancialInstruments core:WithinOneYear 2026-08-31 16654312 bus:Micro-entities 2025-08-15 2026-08-31 16654312 bus:AuditExemptWithAccountantsReport 2025-08-15 2026-08-31 16654312 bus:FilletedAccounts 2025-08-15 2026-08-31 16654312 bus:SmallCompaniesRegimeForAccounts 2025-08-15 2026-08-31 16654312 bus:RegisteredOffice 2025-08-15 2026-08-31 16654312 bus:Director1 2025-08-15 2026-08-31 16654312 bus:PrivateLimitedCompanyLtd 2025-08-15 2026-08-31 16654312 bus:Agent1 2025-08-15 2026-08-31 16654312 countries:EnglandWales 2025-08-15 2026-08-31 iso4217:GBP xbrli:pure

Registration number: 16654312

Jabbari Neurology Ltd

Unaudited Filleted Financial Statements

for the Period from 15 August 2025 to 31 August 2026

 

Jabbari Neurology Ltd

Contents

Company Information

1

Balance Sheet

2 to 3

Notes to the Unaudited Financial Statements

2

 

Jabbari Neurology Ltd

Company Information

Director

Mr Edwin Jabbari

Registered office

49 Birchington Road
London
N8 8HP

Accountants

Sterlings Ltd
Chartered AccountantsLawford House
Albert Place
London
N3 1QA

 

Jabbari Neurology Ltd

(Registration number: 16654312)
Balance Sheet as at 31 August 2026

2026
£

Current assets

10,846

Prepayments and accrued income

943

Creditors: Amounts falling due within one year

(6,298)

Total assets less current liabilities

5,491

Accruals and deferred income

(1,200)

 

4,291

Capital and reserves

4,291

1

General information

The company is a private company limited by share capital, incorporated in England and Wales.

The address of its registered office is:
49 Birchington Road
London
N8 8HP

These financial statements were authorised for issue by the director on 14 October 2026.

Basis of preparation

The financial statements have been prepared under the historical cost convention and in accordance with FRS 105 'The Financial Reporting Standard applicable to the Micro-entities Regime'.

The financial statements are presented in Pounds Sterling, which is also the functional currency of the Company. Rounding of amounts shown in the financial statements is to the nearest Pound.

2

Staff numbers

The average number of persons employed by the company (including the director) during the period, was 1.

 

Jabbari Neurology Ltd

(Registration number: 16654312)
Balance Sheet as at 31 August 2026

For the financial period ending 31 August 2026 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:

•

The members have not required the company to obtain an audit of its accounts for the period in question in accordance with section 476; and

•

The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the provisions applicable to companies subject to the micro entities regime and delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the director has not delivered to the registrar a copy of the Profit and Loss Account.

Approved and authorised by the director on 14 October 2026
 

.........................................
Mr Edwin Jabbari
Director